“4+7”带量采购对地方医药产业的影响及对策——以常州为例  

Impact of Procurement with Quantity on Pharmaceutical Industry and Countermeasures——Taking Changzhou as an Example

作　　者：滕一万 潘华阳 偰蜀江 蒋鹏举[3] TENG Yi-wan;PAN Hua-yang;XIE Shu-jiang;JIANG Peng-ju(Changzhou Centre for Productivity Development,Changzhou 213131,China;Tianning District Science and Technology Bureau of Changzhou,Changzhou 213001,China;Changzhou University,Changzhou 213164,China)

机构地区：[1]常州市生产力发展中心,江苏常州213131 [2]常州市天宁区科技局,江苏常州213001 [3]常州大学,江苏常州213164

出　　处：《药物生物技术》2021年第4期405-407,共3页Pharmaceutical Biotechnology

摘　　要："4+7"带量采购正在全国范围如火如荼开展,对药企、医药行业、患者等产生深远影响。文章通过对"4+7"带量采购进行总结,以常州为例分析了产业发展现状,阐明了当前实际状况,解析了产业发展存在的问题,并提出了合理化建议,为地方医药产业发展出谋划策。Procurement with quantity based on"4+7"cities is in progress nationwide,which has a profound influence on pharmaceutical enterprises,pharmaceutical industry and patients.This paper summarizes procurement with quantity,analyses the current situation of Changzhou,puts forwards some existing problems and rationalization proposals in industrial development,so as to give some suggestions for the development of local pharmaceutical industry.

关 键 词：“4+7” 带量采购 常州 对策 

分 类 号：R95[医药卫生—药学]